Business Description
![Ovid Therapeutics Inc Ovid Therapeutics Inc logo](https://static.gurufocus.com/logos/0C0000B8TQ.png?14)
Ovid Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US6904691010
Description
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 5 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.17 | |||||
Debt-to-EBITDA | -0.23 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -1.73 | |||||
Beneish M-Score | -1.06 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -69.7 | |||||
3-Year EBITDA Growth Rate | 16.2 | |||||
3-Year EPS without NRI Growth Rate | 17.9 | |||||
3-Year FCF Growth Rate | 9.9 | |||||
3-Year Book Growth Rate | 23.2 | |||||
Future 3-5Y Total Revenue Growth Rate | 357.44 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 85.41 | |||||
9-Day RSI | 74.14 | |||||
14-Day RSI | 62 | |||||
6-1 Month Momentum % | -71.62 | |||||
12-1 Month Momentum % | -72.51 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.73 | |||||
Quick Ratio | 5.73 | |||||
Cash Ratio | 5.45 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.4 | |||||
Shareholder Yield % | 0.66 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -11998.59 | |||||
Net Margin % | -5237.15 | |||||
FCF Margin % | -9344.89 | |||||
ROE % | -31.85 | |||||
ROA % | -22.71 | |||||
ROIC % | -185.78 | |||||
ROC (Joel Greenblatt) % | -464.68 | |||||
ROCE % | -56.63 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 150 | |||||
PB Ratio | 0.96 | |||||
Price-to-Tangible-Book | 0.97 | |||||
EV-to-EBIT | -0.35 | |||||
EV-to-Forward-EBIT | -1.01 | |||||
EV-to-EBITDA | -0.35 | |||||
EV-to-Revenue | 41.52 | |||||
EV-to-Forward-Revenue | 41.21 | |||||
EV-to-FCF | -0.44 | |||||
Price-to-Net-Current-Asset-Value | 1.66 | |||||
Price-to-Net-Cash | 1.81 | |||||
Earnings Yield (Greenblatt) % | -285.71 | |||||
FCF Yield % | -62.32 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:OVID
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ovid Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.568 | ||
EPS (TTM) ($) | -0.43 | ||
Beta | -0.4 | ||
Volatility % | 93 | ||
14-Day RSI | 62 | ||
14-Day ATR ($) | 0.079247 | ||
20-Day SMA ($) | 1.022605 | ||
12-1 Month Momentum % | -72.51 | ||
52-Week Range ($) | 0.68 - 4.1 | ||
Shares Outstanding (Mil) | 70.97 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Ovid Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Ovid Therapeutics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Ovid Therapeutics Inc Frequently Asked Questions
What is Ovid Therapeutics Inc(OVID)'s stock price today?
The current price of OVID is $1.21. The 52 week high of OVID is $4.10 and 52 week low is $0.68.
When is next earnings date of Ovid Therapeutics Inc(OVID)?
The next earnings date of Ovid Therapeutics Inc(OVID) is 2024-11-01 Est..
Does Ovid Therapeutics Inc(OVID) pay dividends? If so, how much?
Ovid Therapeutics Inc(OVID) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |